Hi Tech Biosciences India Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2007.
2007 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Hi Tech Biosciences India Private Limited

Hi Tech Biosciences India Private Limited, a active private limited company, was established on 24 April 2007 in Pune, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232PN2007PTC130033. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹3.91 Cr.

Formerly known as Hitech Bio Sciences India Limited, Hitech Bio Sciences India Private Limited. It upholds a compliant status. Employing 97 professional, Its leadership includes Raghavendra Prabhakar Gaikaiwari (Managing Director), Shilpa Anil Wagh (Whole-Time Director). Past directors included Raghavendra Prabhakar Gaikaiwari, Shilpa Anil Wagh, Vijayalaxmi Prabhakar Gaikaiwari. It holds ₹24.55 Cr open charges and ₹30.95 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-2,Unit No. 102103 , Saudamini Complex, S.No.101/1,Bhusari Colony,Paud Road , Ko, Thrud, Pune, Maharashtra, 411038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PN2007PTC130033

  • Registration Number

    130033

  • Incorporation Date

    24 April 2007

  • Authorized Capital

    ₹7.00 Cr

  • Paid-Up Capital

    ₹3.91 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 3.91 Cr
  • Company Age 18 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 24.55 Cr
  • Satisfied Charges ₹ 30.95 Cr
  • Revenue Growth **** 36.76%
  • Profit Growth **** 19.22%
  • Ebitda **** 82.82%
  • Net Worth 9.97%
  • Total Assets **** 21.88%
Company report

Hi Tech Biosciences India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hi Tech Biosciences India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hi Tech Biosciences India Private Limited?
Current Directors
Name Designation Appointment Date Status
Raghavendra Prabhakar Gaikaiwari Managing Director 24 Apr 2007 Current
Shilpa Anil Wagh Whole-Time Director 27 Oct 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jun 2007 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past
Pramod Abcsdd Director 31 Jan 2017 Past
Pramod Abcsdd Director 13 Jan 2019 Past
Pramod Abcsdd Director 23 Jul 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hi Tech Biosciences India.

Hi Tech Biosciences India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.76% increase. The company also saw a substantial improvement in profitability, with a 19.22% increase in profit. The company's net worth moved up by a moderate rise of 9.97%.

Hi Tech Biosciences India revenue growth over time
Hi Tech Biosciences India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 36.76%
*******
*******
*******
*******
Revenue from Operations
*******
 40.77%
*******
*******
*******
*******
Total Assets
*******
 21.88%
*******
*******
*******
*******
Profit or Loss
*******
 19.22%
*******
*******
*******
*******
Net Worth
*******
 9.97%
*******
*******
*******
*******
EBITDA
*******
 82.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hi Tech Biosciences India?

In 2023, Hi Tech Biosciences India had a promoter holding of 96.70% and a public holding of 3.30%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹245,500,000.00

Satisfied Charges

₹309,530,000.00

Charges Breakdown by Lending Institutions
  • Others : 22.55 Cr
  • Sidbi : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
30 Sep 2025 Sidbi ₹2.00 Cr Open
13 Oct 2020 Others ₹22.55 Cr Open
03 Oct 2019 Axis Bank Limited ₹0.43 M Satisfied
20 Mar 2019 Sidbi ₹7.50 M Satisfied
01 Nov 2017 Axis Bank Limited ₹10.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Hi Tech Biosciences India?

Hi Tech Biosciences India has a workforce of 97 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hi Tech Biosciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hi Tech Biosciences India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hi Tech Biosciences India
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 17 May 2012 via Charge ID 10358524 with Biotechnology Industry Research Assistance Council was fully satisfied on 26 Nov 2025. was completed.

  • Charges

    The activity A charge registered on 20 Mar 2019 via Charge ID 100251262 with Sidbi was fully satisfied on 10 Nov 2025. was completed.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 101171408 was registered on 30 Sep 2025. was documented.

  • Annual General Meeting

    The activity Hi Tech Biosciences India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge registered on 29 May 2012 via Charge ID 10358853 with Biotechnology Industry Research Assistance Council was fully satisfied on 21 Apr 2025. was recorded as a recent event.

  • Balance Sheet

    Hi Tech Biosciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hi Tech Biosciences India Private Limited?

The CIN of Hi Tech Biosciences India Private Limited is U24232PN2007PTC130033.

Where is Hi Tech Biosciences India Private Limited headquartered?

Hi Tech Biosciences India Private Limited is headquartered at C-2,Unit No. 102103 , Saudamini Complex, S.No.101/1,Bhusari Colony,Paud Road , Ko, Thrud, Pune, Maharashtra, 411038.

When was Hi Tech Biosciences India Private Limited incorporated?

Hi Tech Biosciences India Private Limited was incorporated on 24 April 2007.

Who are the current directors of Hi Tech Biosciences India Private Limited?

The current directors of Hi Tech Biosciences India Private Limited are

What is the primary industry of Hi Tech Biosciences India Private Limited?

The primary industry of Hi Tech Biosciences India Private Limited is Manufacturing.

Is Hi Tech Biosciences India Private Limited a listed company?

Hi Tech Biosciences India Private Limited is unlisted.

What is the capital structure of Hi Tech Biosciences India Private Limited?

The authorized capital of Hi Tech Biosciences India Private Limited is ₹7.00 Cr, and the paid-up capital is ₹3.91 Cr.

What is the compliance status of Hi Tech Biosciences India Private Limited?

The compliance status of Hi Tech Biosciences India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available